Market Overview
| Study Period | 2021 - 2032 |
|---|---|
| Forecast Data Period | 2027 - 2032 |
| Historical Data Period | 2021 - 2025 |
| Base Year Market Size (2026) | USD 45.07 Million |
| Market Size (2027) | USD 47.60 Million |
| Market Size (2032) | USD 62.57 Million |
| Growth Rate (2027 - 2032) | 5.62 % |
Major Players *Disclaimer: Major Players sorted in no particular order Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0. | |
Netherlands Respiratory Devices Market Analysis by Mordor Intelligence
The Netherlands Respiratory Devices Market size is projected to expand from USD 45.07 million in 2026 and USD 47.60 million in 2027 to USD 62.57 million by 2032, registering a CAGR of 5.62% between 2027 and 2032.
During the COVID-19 pandemic, the demand for major respiratory devices such as ventilators, nebulizers, CPAP, BiPAP, and oxygen concentrators increased due to the high number of COVID-19-infected patients in the country. With the increased severity of COVID-19 in the country, several companies increased their ventilator production to combat the pandemic. For instance, in April 2020, Medtronic ramped up the production of ventilators by more than 40%, increasing the capacity to make and supply the devices to hospitals globally. Also, in April 2020, the Philips Foundation partnered with Refugee Company and its feedstock supplier to provide a loan for two mask-making machines to alleviate the shortage of medical face masks in the Netherlands. This indicates the urgent need for respiratory devices like ventilators, oxygen concentrators, and nebulizers, especially for COVID-19 patients in the country. Moreover, with the released COVID-19 restrictions and resumed treatment and elective surgery procedures, the demand for respiratory devices is expected to increase over the forecast period.
Certain factors attributing to the market growth are the increasing prevalence of respiratory disorders and growing applications in home care settings.
The increasing burden of respiratory diseases such as asthma, lung cancer, chronic obstructive pulmonary disease (COPD), sleep apnea, and tuberculosis among the population is also expected to increase the market growth over the forecast period. For instance, as per GLOBOCAN 2020 factsheet, about 13,500 new lung cancer cases were reported in the Netherlands in 2020. Also, the increasing number of smokers in the country raises the risk of developing lung cancer and other respiratory problems, which, in turn, is expected to increase the demand for respiratory devices. For instance, as per the statistics published by Netherlands Expertise Center for Tobacco Control in June 2022, about 20.6% of adults aged 18 years and older in the Netherlands smoked in 2021. Thus, the rising prevalence of respiratory issues among the population is expected to increase the demand for ventilators and other respiratory devices, thereby propelling the market's growth.
Additionally, as per an article published in European Respiratory Journal in July 2021, it was found that the prevalence of chronic obstructive pulmonary disease (COPD) is anticipated to increase in Europe (including the Netherlands) due to rising risk factors like smoking and air pollution. Similarly, from an article published in PLOS One in November 2022, it was found that the frequency of COPD in patients with COVID-19 was the highest in the Netherlands at 17% in 2021. Thus, the expected increase in the number of people suffering from COPD in the country and the rising prevalence is expected to increase the demand for inhalers and nebulizers to deliver various COPD medications to patients, which, in turn, is anticipated to propel the demand for respiratory devices over the forecast period.
Furthermore, rising government initiatives are also contributing to the market's growth. For instance, in May 2021, the Netherlands shipped 449 ventilators, 100 oxygen concentrators, and other medical supplies to India to fight against the COVID-19 pandemic. This is anticipated to increase the company's focus on accelerating the production of ventilators and oxygen concentrators, thereby propelling the market's growth.
Therefore, owing to the aforementioned factors, the market studied is expected to grow over the forecast period. However, the high cost of devices such as ventilators and respiratory humidifier are likely to impede market growth during the forecast period.
Note: Market numbers in this report are based on Mordor Intelligence's proprietary estimation framework, which combines nine months of actuals with Q4 projections for base year 2026.
Market Trends and Insights
Ventilators Segment is Expected to Grow Over the Forecasted Period
The ventilator segment is expected to witness substantial growth in the respiratory devices market during the forecast period, driven by the increasing burden of respiratory disorders and the rising incidence of critical conditions requiring respiratory support, such as chronic obstructive pulmonary disease (COPD), pneumonia, acute respiratory distress syndrome (ARDS), stroke, cardiac arrest, and traumatic brain injuries. In addition, the growing geriatric population, expanding demand for intensive care services, and increasing adoption of home-based ventilation solutions are expected to support segment growth. Furthermore, continuous technological advancements in ventilator systems, including portable and non-invasive ventilation devices, are anticipated to enhance patient care and contribute to the expansion of the segment during the forecast period.
In addition, the increased number of COVID-19 infections among the population also increased the demand for ventilators in healthcare settings across the world, which, in turn, impacted the growth of the segment. For instance, an article published in the Nature Public Health Emergency Collection in February 2022 stated that the male population in the country was at high risk of mortality during the first three months of the outbreak in the Netherlands. Also, as per another article published in PLOS One in October 2021, it has been observed that moderate and severe traumatic brain injury cases were common in the elderly population and are the primary cause of death in people with severe trauma injuries. Thus, the high burden of brain injuries is also expected to increase the demand for ventilators over the forecast period, propelling the market's growth.
Furthermore, the companies increased their ventilator production to treat patients with respiratory insufficiency during the COVID-19 pandemic. For instance, Royal Philips doubled the production of its hospital ventilators in May 2020 and achieved a four-fold increase by the third quarter of 2020. Also, in April 2020, Philips introduced a new Philips Respironics E30 ventilator as a readily available ventilation alternative during the COVID-19 crisis in situations. Thus, such initiatives taken by the companies are expected to have a positive impact on the segment's growth.
Thus, owing to the aforementioned factors, such as the high burden of coronavirus infection, increasing prevalence of traumatic brain injury, and increasing product launches, the segment studied is expected to grow significantly during the forecast period.
Masks Segment is Expected to Have Significant Market Share Over the Forecast Period
The masks segment is anticipated to record notable growth in the Netherlands respiratory devices market over the forecast period. This growth is supported by the continued emphasis on infection prevention, increasing awareness regarding respiratory health, and the sustained demand for protective respiratory equipment across healthcare and community settings. In addition, the prevalence of respiratory infections, periodic outbreaks of communicable diseases, and ongoing product development initiatives by manufacturers are expected to contribute to segment expansion during the forecast period.
The number of patients suffering from tuberculosis has increased in the country, which is anticipated to raise the demand for respirators to protect against inhaled toxins, propelling the market's growth. For instance, according to the data published by ECDC, in March 2022, 680 people with tuberculosis (TB) were reported in the Netherlands in 2021 compared to 622 patients with TB in 2020. Thus, the high number of TB infections in patients is expected to increase the demand for surgical masks to prevent the inhalation and spread of airborne droplet nuclei, thereby boosting segment growth.
Additionally, different types of masks are used to prevent and treat respiratory diseases. For instance, venturi masks and nasal prongs masks are used to treat acute respiratory failure (ARF) in chronic obstructive pulmonary disease (COPD).
Furthermore, government-led public health measures aimed at reducing the transmission of respiratory infections are expected to support demand for masks in the Netherlands. For instance, in January 2022, the Dutch government strengthened face-covering requirements in several public indoor settings as part of its efforts to limit the spread of COVID-19. Such measures increased the use of protective masks among the general population and healthcare workers, thereby contributing to segment growth. Continued emphasis on infection control and public health preparedness is expected to sustain demand for masks during the forecast period.
Therefore, owing to factors such as the increasing prevalence of respiratory disorders, growing awareness regarding respiratory health, expanding adoption of home-based respiratory care, and continuous advancements in respiratory support technologies, the market is expected to witness growth over the forecast period. However, limited reimbursement coverage for certain respiratory devices and disparities in access to advanced respiratory care solutions may act as key challenges, potentially restraining market expansion during the forecast period.
Competitive Landscape
Market Concentration
The Dutch respiratory devices market is moderately competitive with several major players. Some of the strategies implemented include agreements, collaborative models, business expansion, and product development. Some of the major players are DeVilbiss Healthcare LLC, Dragerwerk AG, Fisher & Paykel Healthcare Ltd, GE Healthcare, Getinge AB, and GlaxoSmithKline PLC.
Netherlands Respiratory Devices Industry Leaders
-
DeVilbiss Healthcare LLC
-
Dragerwerk AG
-
Fisher & Paykel Healthcare Ltd
-
GE Healthcare
-
Getinge AB
- *Disclaimer: Major Players sorted in no particular order
Netherlands Respiratory Devices Market Companies Covered in this Report
- Drive DeVilbiss Healthcare
- Dragerwerk
- Fisher & Paykel Healthcare
- GE Healthcare
- Getinge
- GlaxoSmithKline
- Invacare
- Koninklijke Philips
- Medtronic
- DEMCON Macawi Medical Systems
Recent Industry Developments in Netherlands Respiratory Devices Market
- September 2022: Onera Health launched its ground-breaking solution, Onera Sleep Test System and the Onera Digital Health Platform, to diagnose sleep disorders. The company provides Onera's Polysomnography-as-a-Service solution in the Netherlands.
- June 2021: Onera BV received a CE (Certificate of Conformity) for its patch-based home sleep testing system.
Netherlands Respiratory Devices Market Report Scope
As per the scope of the report, respiratory devices include respiratory diagnostic devices, therapeutic devices, and breathing devices for administering long-term artificial respiration. It may also include a breathing apparatus used for resuscitation by forcing oxygen into the lungs of a person who has undergone asphyxia.
The Dutch respiratory devices market is segmented by type (diagnostic and monitoring devices (spirometers, sleep test devices, peak flow meters, and other diagnostic and monitoring devices), therapeutic devices (ventilators, inhalers, CPAP devices, and other therapeutic devices), and disposables (masks, breathing circuits, and other disposables). The report offers values in USD million for all the above-mentioned segments.
Segmentation Overview
By Type
| Diagnostic and Monitoring Devices | Spirometers |
| Sleep Test Devices | |
| Peak Flow Meters | |
| Other Diagnostic and Monitoring Devices | |
| Therapeutic Devices | Ventilators |
| Inhalers | |
| CPAP Devices | |
| Other Therapeutic Devices | |
| Disposables | Masks |
| Breathing Circuits | |
| Other Disposables |
| By Type | Diagnostic and Monitoring Devices | Spirometers |
| Sleep Test Devices | ||
| Peak Flow Meters | ||
| Other Diagnostic and Monitoring Devices | ||
| Therapeutic Devices | Ventilators | |
| Inhalers | ||
| CPAP Devices | ||
| Other Therapeutic Devices | ||
| Disposables | Masks | |
| Breathing Circuits | ||
| Other Disposables | ||
Key Questions Answered in the Report
What is the current Netherlands Respiratory Devices Market size?
The Netherlands Respiratory Devices Market is projected to register a CAGR of 5.62% during the forecast period (2027-2032)
Who are the key players in Netherlands Respiratory Devices Market?
DeVilbiss Healthcare LLC, Dragerwerk AG, Fisher & Paykel Healthcare Ltd, GE Healthcare and Getinge AB are the major companies operating in the Netherlands Respiratory Devices Market.
What years does this Netherlands Respiratory Devices Market cover?
The report covers the Netherlands Respiratory Devices Market historical market size for years: 2021, 2022, 2023, 2024, and 2025. The report also forecasts the Netherlands Respiratory Devices Market size for years: 2027, 2028, 2029, 2030, 2031, and 2032.